News May 18, 2021 Biopôle’s new “Start-Up Fund” aims to promote early access to innovation in the life sciences Biopôle has announced the launch of the “Biopôle Start-Up Fund”, a new fund dedicated to supporting the next generation of impact-driven life sci...
News May 12, 2021 IoT-powered cleantech start-up Droople raises CHF 1.5 million Three years after its launch and to meet growing demand for its digital water management solutions, Vaud-based start-up Droople has raised CHF 1....
News May 11, 2021 EPFL spin-off bNovate expands globally after raising CHF 5 million With its connected solutions allowing bacteria measurement in water in only 20 minutes, industrial microbiology specialist bNovate Technologies h...
News May 11, 2021 Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million A biopharmaceutical company focused on developing innovative ophthalmic treatments, Oculis has announced the closing of an oversubscribed $ 57 mi...
News May 10, 2021 Lonza invests CHF 650 million in a new large-scale production facility in Visp Biopharmaceutical giant Lonza has announced expansion plans for next-generation mammalian manufacturing facilities on its Visp site. With an inve...
News May 06, 2021 Berna Biotech Pharma and Swiss Biotech Center to develop second-generation covid-19 vaccine Swiss biotech companies Berna Biotech Pharma and Swiss Biotech Center are joining forces to develop a second-generation vaccine against covid-19....
News May 05, 2021 Transcriptomics solutions specialist Alithea Genomics raises CHF 150’000 Lausanne-based Alithea Genomics has been awarded CHF 150,000 from Venture Kick for the development of its novel technology that enables a high th...
News May 05, 2021 Vaud-based start-up Dpendent seeks to make drones more independent Based at the heart of the “Drone Valley”, Dpendent has just received a loan of CHF 100’000 to develop a new technology aimed at increasing the in...
News May 03, 2021 EPFL spin-off ONWARD raises $ 32 million for its spinal cord therapies ONWARD has raised $ 32 million to further develop and commercialize its ARC therapy stimulating the spinal cord to restore movement.
News May 03, 2021 Geneva-based biometrics specialist TECH5 receives $ 2.5 million Recognizing TECH5’s leadership and growth potential in identity management and digital ID, the company received $ 2.5 million of investment from ...
News Apr 30, 2021 Ferring Biologics Innovation Center opens at Biopôle Swedish biopharmaceutical group Ferring Pharmaceuticals has opened a state-of-the-art innovation center at Biopôle, adding a new hub for biologic...
News Apr 30, 2021 ADC Therapeutics receives FDA approval for its lymphoma cancer treatment ZYNLONTA Oncology biotechnology company ADC Therapeutics has received the first FDA approval for ZYNLONTA, its lead drug candidate for the treatment of ad...
News Apr 27, 2021 Lonza invests CHF 200 million in a new production facility in Visp Biopharmaceutical company Lonza will build a new manufacturing facility dedicated to small molecules at its site in Visp. The new investment amou...
News Apr 26, 2021 H55 will provide its battery technology to the world’s first certified all electric commercial airplane The largest seaplane airline operator, the global leader in electric propulsion technology, and the Valais-based electric system and battery stor...
News Apr 26, 2021 Record year for Western Switzerland’s biotech industry Biotechnology companies based in Switzerland have experienced record investments in the pandemic year 2020. The western Switzerland region, home ...
News Apr 21, 2021 Geneva-based fintech Taurus launches the world’s first regulated digital assets marketplace Digital asset infrastructure company Taurus received a license from the FINMA to operate the world’s first independent regulated marketplace for ...
Success stories Apr 21, 2021 Deloitte’s Future of Health Initiative: “We have all of the parts of the value chain here, from R&D to manufacturing to commercialization.“ Switzerland is an important hub for the life sciences industry. It is the second largest exporter of packaged medicines in the world and home to ...
News Apr 20, 2021 Calcification propensity diagnostics start-up Calciscon raises CHF 2.5 million Bernese medtech start-up Calciscon, the developer of the first and only diagnostic blood test for the assessment of the formation of crystalline ...